These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 1984099

  • 1. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A, Schramek P.
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [Abstract] [Full Text] [Related]

  • 2. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W, Lycklama à Nijeholt AA, Kropman RF, Vermeij P, Zwartendijk J.
    Eur Urol; 1994 Jan; 26(4):319-21. PubMed ID: 7713130
    [Abstract] [Full Text] [Related]

  • 3. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
    Allen RP, Engel RM, Smolev JK, Brendler CB.
    J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
    Bechara A, Casabé A, Chéliz G, Romano S, Fredotovich N.
    J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A, Casabé A, Chéliz G, Romano S, Rey H, Fredotovich N.
    J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R, Asakawa M, Kawashima H, Yoshimura R, Maekawa T, Kashiwara N, Tanaka H, Nishio S.
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.
    Zaher TF.
    Int Urol Nephrol; 1998 Feb; 30(2):193-6. PubMed ID: 9607891
    [Abstract] [Full Text] [Related]

  • 15. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B, Donatucci CF, Kaula N, Lue TF.
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E1 therapy for impotence, comparison with papaverine.
    Earle CM, Keogh EJ, Wisniewski ZS, Tulloch AG, Lord DJ, Watters GR, Glatthaar C.
    J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y, Lidgi S, Moskovitz B, Levin RD.
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S, Iwai Y, Yasumoto R, Matsuda J, Kawano M, Omachi T, Kono T, Yamamoto S, Sakakura T, Minami H.
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.